Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
US10434112B2 · kind B2 · utility
2Cited by
22References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 18, 2017 |
| Grant date | Oct 8, 2019 |
| Priority date | — |
| Expiry date | Apr 18, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 (FPR2).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.